James HowardTonsgardJames Howard Tonsgard41.78927490000000-87.60125000000000420Tonsgard, James HowardClinical Associate Professorplugins:FeaturedVideosFeatured Videosprns:coAuthorOfcoauthor ofprns:emailEncryptedemail addressprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:physicalNeighborOfphysical neighborprns:pluginSearchableDataProfilesRNS Plugin Searchable Dataprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:similarTosimilar toprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierAddressvivo:addressCitycityvivo:addressPostalCodepostal codevivo:addressStatestate or provincevivo:authorInAuthorshipselected publicationsvivo:authorRankauthor rank in publicationAuthorshipDepartmentvivo:hasResearchArearesearch areasvivo:hrJobTitleHR job titleInformation Resourcevivo:linkAnchorTextlink anchor textvivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcevivo:mailingAddressmailing addressvivo:orcidIdORCID idvivo:personInPositionpositionsPositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titleURLLinkvivo:webpagewebpagerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonJeanDecety02dqDrUMOfnamXNnYUHhvWD+6g==Jean Decety41.7886000000000087.598699999999993501Decety, JeanProfessorD005227Chemicals & Drugs811290.930415Fatty AcidsAuthorship 114836Authorship 107956Authorship 108391Authorship 111443Authorship 110942Authorship 147941Authorship 173444Authorship 1607914Authorship 174672Authorship 20282Authorship 222924Authorship 131842831350851Polster SP, Dougherty MC, Zeineddine HA, Lyne SB, Smith HL, MacKenzie C, Pytel P, Yang CW, Tonsgard JH, Warnke PC, Frim DMNeurosurgeryDural Ectasia in Neurofibromatosis 1: Case Series, Management, and Review. Neurosurgery. 2020 05 01; 86(5):646-655.Neurosurgery2020-05-01T00:00:002020Dural Ectasia in Neurofibromatosis 1: Case Series, Management, and Review.Authorship 28311D009456Disorders19360.967535Neurofibromatosis 1Authorship 26801Authorship 26881Authorship 1336261031626572Plotkin SR, Duda DG, Muzikansky A, Allen J, Blakeley J, Rosser T, Campian JL, Clapp DW, Fisher MJ, Tonsgard J, Ullrich N, Thomas C, Cutter G, Korf B, Packer R, Karajannis MAJournal of clinical oncology : official journal of the American Society of Clinical OncologyMulticenter, Prospective, Phase II and Biomarker Study of High-Dose Bevacizumab as Induction Therapy in Patients With Neurofibromatosis Type 2 and Progressive Vestibular Schwannoma. J Clin Oncol. 2019 12 10; 37(35):3446-3454.J Clin Oncol2019-10-18T00:00:002019Multicenter, Prospective, Phase II and Biomarker Study of High-Dose Bevacizumab as Induction Therapy in Patients With Neurofibromatosis Type 2 and Progressive Vestibular Schwannoma.Authorship 299381Authorship 1345561231797581Payne JM, Hearps SJC, Walsh KS, Paltin I, Barton B, Ullrich NJ, Haebich KM, Coghill D, Gioia GA, Cantor A, Cutter G, Tonsgard JH, Viskochil D, Rey-Casserly C, Schorry EK, Ackerson JD, Klesse L, Fisher MJ, Gutmann DH, Rosser T, Packer RJ, Korf B, Acosta MT, North KN, NF Clinical Trials ConsortiumAnnals of clinical and translational neurologyReproducibility of cognitive endpoints in clinical trials: lessons from neurofibromatosis type 1. Ann Clin Transl Neurol. 2019 12; 6(12):2555-2565.Ann Clin Transl Neurol2019-12-03T00:00:002019Reproducibility of cognitive endpoints in clinical trials: lessons from neurofibromatosis type 1.Authorship 1348621031838937Payne JM, Haebich KM, MacKenzie R, Walsh KS, Hearps SJC, Coghill D, Barton B, Pride NA, Ullrich NJ, Tonsgard JH, Viskochil D, Schorry EK, Klesse L, Fisher MJ, Gutmann DH, Rosser T, Packer RJ, Korf B, Acosta MT, Bellgrove MA, North KNJournal of attention disordersCognition, ADHD Symptoms, and Functional Impairment in Children and Adolescents With Neurofibromatosis Type 1. J Atten Disord. 2021 06; 25(8):1177-1186.J Atten Disord2019-12-14T00:00:002019Cognition, ADHD Symptoms, and Functional Impairment in Children and Adolescents With Neurofibromatosis Type 1.Authorship 33113Authorship 58553Authorship 401204Authorship 3888124D012202Disorders9220.994472Reye SyndromeAuthorship 9603Authorship 55061Authorship 82851Authorship 62101Authorship 62331Authorship 85111Authorship 92494Authorship 58151Authorship 140861Authorship 143513Authorship 36291Authorship 499918371066Kundu RK, Getz GS, Tonsgard JHJournal of lipid researchInduction of (omega-1)-oxidation of monocarboxylic acids by acetylsalicylic acid. J Lipid Res. 1993 Jul; 34(7):1187-99.J Lipid Res1993-07-01T00:00:001993Induction of (omega-1)-oxidation of monocarboxylic acids by acetylsalicylic acid.8466512Aoyama T, Uchida Y, Kelley RI, Marble M, Hofman K, Tonsgard JH, Rhead WJ, Hashimoto TBiochemical and biophysical research communicationsA novel disease with deficiency of mitochondrial very-long-chain acyl-CoA dehydrogenase. Biochem Biophys Res Commun. 1993 Mar 31; 191(3):1369-72.Biochem Biophys Res Commun1993-03-31T00:00:001993A novel disease with deficiency of mitochondrial very-long-chain acyl-CoA dehydrogenase.WilliamDobynsWilliam B. Dobyns0.000000000000000.000000000000002964Dobyns, WilliamPROFESSOR 9375928Tonsgard JH, Yelavarthi KK, Cushner S, Short MP, Lindgren VAmerican journal of medical geneticsDo NF1 gene deletions result in a characteristic phenotype? Am J Med Genet. 1997 Nov 28; 73(1):80-6.Am J Med Genet1997-11-28T00:00:001997Do NF1 gene deletions result in a characteristic phenotype?10805199Nadig M, Munshi I, Short MP, Tonsgard JH, Sullivan C, Frim DMJournal of child neurologyA child with neurofibromatosis-1 and a lumbar epidural arteriovenous malformation. J Child Neurol. 2000 Apr; 15(4):273-5.J Child Neurol2000-04-01T00:00:002000A child with neurofibromatosis-1 and a lumbar epidural arteriovenous malformation.10849133Miller MB, Tonsgard JH, Soltani KInternational journal of dermatologyLate-onset neurofibromatosis in a liver transplant recipient. Int J Dermatol. 2000 May; 39(5):376-9.Int J Dermatol2000-05-01T00:00:002000Late-onset neurofibromatosis in a liver transplant recipient.9633723Tonsgard JH, Kwak SM, Short MP, Dachman AHNeurologyCT imaging in adults with neurofibromatosis-1: frequent asymptomatic plexiform lesions. Neurology. 1998 Jun; 50(6):1755-60.Neurology1998-06-01T00:00:001998CT imaging in adults with neurofibromatosis-1: frequent asymptomatic plexiform lesions.10360395Stevenson DA, Birch PH, Friedman JM, Viskochil DH, Balestrazzi P, Boni S, Buske A, Korf BR, Niimura M, Pivnick EK, Schorry EK, Short MP, Tenconi R, Tonsgard JH, Carey JCAmerican journal of medical geneticsDescriptive analysis of tibial pseudarthrosis in patients with neurofibromatosis 1. Am J Med Genet. 1999 Jun 11; 84(5):413-9.Am J Med Genet1999-06-11T00:00:001999Descriptive analysis of tibial pseudarthrosis in patients with neurofibromatosis 1.1752948Kundu RK, Tonsgard JH, Getz GSThe Journal of clinical investigationInduction of omega-oxidation of monocarboxylic acids in rats by acetylsalicylic acid. J Clin Invest. 1991 Dec; 88(6):1865-72.J Clin Invest1991-12-01T00:00:001991Induction of omega-oxidation of monocarboxylic acids in rats by acetylsalicylic acid.12646736Lee MC, Frank JI, Kahana M, Tonsgard JH, Frim DMPediatric neurosurgeryDecompressive hemicraniectomy in a 6-year-old male after unilateral hemispheric stroke. Case report and review. Pediatr Neurosurg. 2003 Apr; 38(4):181-5.Pediatr Neurosurg2003-04-01T00:00:002003Decompressive hemicraniectomy in a 6-year-old male after unilateral hemispheric stroke. Case report and review.Authorship 143516533507822Weiss BD, Wolters PL, Plotkin SR, Widemann BC, Tonsgard JH, Blakeley J, Allen JC, Schorry E, Korf B, Robison NJ, Goldman S, Vinks AA, Emoto C, Fukuda T, Robinson CT, Cutter G, Edwards L, Dombi E, Ratner N, Packer R, Fisher MJJournal of clinical oncology : official journal of the American Society of Clinical OncologyNF106: A Neurofibromatosis Clinical Trials Consortium Phase II Trial of the MEK Inhibitor Mirdametinib (PD-0325901) in Adolescents and Adults With NF1-Related Plexiform Neurofibromas. J Clin Oncol. 2021 03 01; 39(7):797-806.J Clin Oncol2021-01-28T00:00:002021NF106: A Neurofibromatosis Clinical Trials Consortium Phase II Trial of the MEK Inhibitor Mirdametinib (PD-0325901) in Adolescents and Adults With NF1-Related Plexiform Neurofibromas.2064600Tonsgard JH, Meredith SCThe Biochemical journalCharacterization of the binding sites for dicarboxylic acids on bovine serum albumin. Biochem J. 1991 Jun 15; 276 ( Pt 3):569-75.Biochem J1991-06-15T00:00:001991Characterization of the binding sites for dicarboxylic acids on bovine serum albumin.Psychiatry and Behavioral Neuroscience-ResearchRadiology-Abdominal ImagingRadiology-Vascular/Interventional Radiology2354356Hammond DN, Lee HJ, Tonsgard JH, Wainer BHBrain researchDevelopment and characterization of clonal cell lines derived from septal cholinergic neurons. Brain Res. 1990 Apr 02; 512(2):190-200.Brain Res1990-04-02T00:00:001990Development and characterization of clonal cell lines derived from septal cholinergic neurons.19671848Evans DG, Kalamarides M, Hunter-Schaedle K, Blakeley J, Allen J, Babovic-Vuskanovic D, Belzberg A, Bollag G, Chen R, DiTomaso E, Golfinos J, Harris G, Jacob A, Kalpana G, Karajannis M, Korf B, Kurzrock R, Law M, McClatchey A, Packer R, Roehm P, Rubenstein A, Slattery W, Tonsgard JH, Welling DB, Widemann B, Yohay K, Giovannini MClinical cancer research : an official journal of the American Association for Cancer ResearchConsensus recommendations to accelerate clinical trials for neurofibromatosis type 2. Clin Cancer Res. 2009 Aug 15; 15(16):5032-5039.Clin Cancer Res2009-08-11T00:00:002009Consensus recommendations to accelerate clinical trials for neurofibromatosis type 2.16818170Tonsgard JHSeminars in pediatric neurologyClinical manifestations and management of neurofibromatosis type 1. Semin Pediatr Neurol. 2006 Mar; 13(1):2-7.Semin Pediatr Neurol2006-03-01T00:00:002006Clinical manifestations and management of neurofibromatosis type 1.2059253Tonsgard JH, Stephens JK, Rhead WJ, Penn D, Horwitz AL, Kirschner BS, Whitington PF, Berger S, Tripp MEPediatric neurologyDefect in fatty acid oxidation: laboratory and pathologic findings in a patient. Pediatr Neurol. 1991 Mar-Apr; 7(2):125-30.Pediatr Neurol1991-03-01T00:00:001991Defect in fatty acid oxidation: laboratory and pathologic findings in a patient.2144730Tonsgard JH, Tung B, Kornafel KS, Getz GSThe Biochemical journalEnvironmentally induced differential amplification of mitochondrial populations. Biochem J. 1990 Sep 01; 270(2):511-8.Biochem J1990-09-01T00:00:001990Environmentally induced differential amplification of mitochondrial populations.Neurological Surgery20034979Pytel P, Karrison T, Tonsgard JH, Krausz T, Montag AGInternational journal of surgical pathologyNeoplasms with schwannian differentiation express transcription factors known to regulate normal schwann cell development. Int J Surg Pathol. 2010 Dec; 18(6):449-57.Int J Surg Pathol2009-12-24T00:00:002009Neoplasms with schwannian differentiation express transcription factors known to regulate normal schwann cell development.3746531Tonsgard JHThe Journal of pediatricsSerum dicarboxylic acids in patients with Reye syndrome. J Pediatr. 1986 Sep; 109(3):440-5.J Pediatr1986-09-01T00:00:001986Serum dicarboxylic acids in patients with Reye syndrome.7054762Tonsgard JH, Huttenlocher PR, Thisted RAPediatricsLactic acidemia in Reye's syndrome. Pediatrics. 1982 Jan; 69(1):64-9.Pediatrics1982-01-01T00:00:001982Lactic acidemia in Reye's syndrome.7312481Tonsgard JH, Huttenlocher PRPediatricsSalicylates and Reye's syndrome. Pediatrics. 1981 Nov; 68(5):747-8.Pediatrics1981-11-01T00:00:001981Salicylates and Reye's syndrome.7674372Alexander JJ, Banerjee P, Dawson G, Tonsgard JHJournal of neuroscience researchHyperammonemia increases serotonin 1A receptor expression in both rat hippocampus and a transfected hippocampal cell line, HN2-5. J Neurosci Res. 1995 May 01; 41(1):105-10.J Neurosci Res1995-05-01T00:00:001995Hyperammonemia increases serotonin 1A receptor expression in both rat hippocampus and a transfected hippocampal cell line, HN2-5.8232957Kossak BD, Schmidt-Sommerfeld E, Schoeller DA, Rinaldo P, Penn D, Tonsgard JHNeurologyImpaired fatty acid oxidation in children on valproic acid and the effect of L-carnitine. Neurology. 1993 Nov; 43(11):2362-8.Neurology1993-11-01T00:00:001993Impaired fatty acid oxidation in children on valproic acid and the effect of L-carnitine.Authorship 1477481134230198Wolters PL, Vranceanu AM, Thompson HL, Martin S, Merker VL, Baldwin A, Barnett C, Koetsier KS, Hingtgen CM, Funes CJ, Tonsgard JH, Schorry EK, Allen T, Smith T, Franklin B, Reeve S, REiNS International CollaborationNeurologyCurrent Recommendations for Patient-Reported Outcome Measures Assessing Domains of Quality of Life in Neurofibromatosis Clinical Trials. Neurology. 2021 08 17; 97(7 Suppl 1):S50-S63.Neurology2021-07-06T00:00:002021Current Recommendations for Patient-Reported Outcome Measures Assessing Domains of Quality of Life in Neurofibromatosis Clinical Trials.3508062Tonsgard JH, Harwicke N, Levine SCPediatric neurologyKluver-Bucy syndrome in children. Pediatr Neurol. 1987 May-Jun; 3(3):162-5.Pediatr Neurol1987-05-01T00:00:001987Kluver-Bucy syndrome in children.4031073Tonsgard JH, Getz GSThe Journal of clinical investigationEffect of Reye's syndrome serum on isolated chinchilla liver mitochondria. J Clin Invest. 1985 Aug; 76(2):816-25.J Clin Invest1985-08-01T00:00:001985Effect of Reye's syndrome serum on isolated chinchilla liver mitochondria.3183053Tonsgard JH, Mendelson SA, Meredith SCThe Journal of clinical investigationBinding of straight-chain saturated dicarboxylic acids to albumin. J Clin Invest. 1988 Nov; 82(5):1567-73.J Clin Invest1988-11-01T00:00:001988Binding of straight-chain saturated dicarboxylic acids to albumin.3775382Hammond DN, Wainer BH, Tonsgard JH, Heller AScience (New York, N.Y.)Neuronal properties of clonal hybrid cell lines derived from central cholinergic neurons. Science. 1986 Dec 05; 234(4781):1237-40.Science1986-12-05T00:00:001986Neuronal properties of clonal hybrid cell lines derived from central cholinergic neurons.8254451Tonsgard JH, Oesterle CSJournal of pediatric ophthalmology and strabismusThe ophthalmologic presentation of NF-2 in childhood. J Pediatr Ophthalmol Strabismus. 1993 Sep-Oct; 30(5):327-30.J Pediatr Ophthalmol Strabismus1993-09-01T00:00:001993The ophthalmologic presentation of NF-2 in childhood.2496274Tonsgard JHLaboratory investigation; a journal of technical methods and pathologyEffect of Reye's syndrome serum on the ultrastructure of isolated liver mitochondria. Lab Invest. 1989 Apr; 60(4):568-73.Lab Invest1989-04-01T00:00:001989Effect of Reye's syndrome serum on the ultrastructure of isolated liver mitochondria.4009343Tonsgard JHThe Journal of pediatricsUrinary dicarboxylic acids in Reye syndrome. J Pediatr. 1985 Jul; 107(1):79-84.J Pediatr1985-07-01T00:00:001985Urinary dicarboxylic acids in Reye syndrome.9475518Alexander JJ, Snyder A, Tonsgard JHNeurochemical researchOmega-oxidation of monocarboxylic acids in rat brain. Neurochem Res. 1998 Feb; 23(2):227-33.Neurochem Res1998-02-01T00:00:001998Omega-oxidation of monocarboxylic acids in rat brain.1313544Maselli RA, Burnett ME, Tonsgard JHMuscle & nerveIn vitro microelectrode study of neuromuscular transmission in a case of botulism. Muscle Nerve. 1992 Mar; 15(3):273-6.Muscle Nerve1992-03-01T00:00:001992In vitro microelectrode study of neuromuscular transmission in a case of botulism.8352858Taravath S, Tonsgard JHPediatric neurologyCerebral malformations in Carpenter syndrome. Pediatr Neurol. 1993 May-Jun; 9(3):230-4.Pediatr Neurol1993-05-01T00:00:001993Cerebral malformations in Carpenter syndrome.SeanPolsterSean Polster41.7886000000000087.598699999999994144Polster, Sean0000-0002-3229-5021Assistant Professorhttp://hbpl.uchicago.edudewitlabhttps://radiology.uchicago.edu/sections-programs/virtual-colonoscopyVirtual colonoscopyhttp://https://www.ucfibroids.com/Fibroid Treatment Centerhttps://vctraining.uchicago.edu/Virtual colonoscopy training https://www.ucprostate.com/Prostate Artery Embolizationhttp://www.ucfilter.com/IVC Filter ClinicD016518Disorders8110.991032Neurofibromatosis 2D017253Disorders690.993496NeurofibromatosesAuthorship 162356837010875Plotkin SR, Allen J, Dhall G, Campian JL, Clapp DW, Fisher MJ, Jain RK, Tonsgard J, Ullrich NJ, Thomas C, Edwards LJ, Korf B, Packer R, Karajannis MA, Blakeley JONeuro-oncologyMulticenter, prospective, phase II study of maintenance bevacizumab for children and adults with NF2-related schwannomatosis and progressive vestibular schwannoma. Neuro Oncol. 2023 08 03; 25(8):1498-1506.Neuro Oncol2023-08-03T00:00:002023Multicenter, prospective, phase II study of maintenance bevacizumab for children and adults with NF2-related schwannomatosis and progressive vestibular schwannoma.Human GeneticsMedicinePathologyPediatricsUniversity of ChicagoPeterPytelx3JwH6QZOfnamXNnYUHhvWD+6g==Peter Pytel41.78927490000000-87.601250000000001091Pytel, PeterProfessorJon E.GrantJon E. Grant41.78927490000000-87.601250000000001148Grant, Jon E.ProfessorCarolMacmillanCarol Macmillan41.78927490000000-87.601250000000001446Macmillan, CarolAssociate ProfessorRakeshNavulurixWxoHbQZDP7QsWhlZE/h/2r95oW/+rEQZXpyf+6KFXgY71tKRakesh Navuluri41.78927490000000-87.601250000000001540Navuluri, RakeshAssociate ProfessorJanardanKhandekarJanardan Khandekar41.78927490000000-87.601250000000001689Khandekar, JanardanClinical ProfessorAbraham H.DachmanAbraham H. Dachman41.78927490000000-87.601250000000001814Dachman, Abraham H.Professor24229851Klein-Tasman BP, Janke KM, Luo W, Casnar CL, Hunter SJ, Tonsgard J, Trapane P, van der Fluit F, Kais LAJournal of the International Neuropsychological Society : JINSCognitive and psychosocial phenotype of young children with neurofibromatosis-1. J Int Neuropsychol Soc. 2014 Jan; 20(1):88-98.J Int Neuropsychol Soc2013-11-15T00:00:002013Cognitive and psychosocial phenotype of young children with neurofibromatosis-1.StavrosIonidesStavros Ionides41.78927490000000-87.601250000000002109Ionides, StavrosClinical AssociateStephen C.MeredithStephen C. Meredith41.78927490000000-87.601250000000002188Meredith, Stephen C.ProfessorWimVan DrongelenwHRoBaUHFuL5hHlsaUXv9Gq0+s+oWim Van Drongelen41.78927490000000-87.6012500000000030Van Drongelen, WimProfessor1.809150.00450255257research areas0.2560850.023257716coauthor of13.44782.5335260similar to1145selected publicationsYusukeNakamuraYusuke Nakamura41.78927490000000-87.60125000000000582Nakamura, YusukeEmeritus/Emerita, ProfessorGodfreyGetzGodfrey S. Getz41.78927490000000-87.60125000000000725Getz, GodfreyEmeritus/Emerita, ProfessorHarrietDe Wit32ZsHIEMFujY33h3ZAj78G3z/Mq65vtbdGw=Harriet De Wit41.78927490000000-87.60125000000000750De Wit, HarrietProfessortrue1PROFESSOR PROFESSOR true1Emeritus/Emerita, ProfessorEmeritus/Emerita, Professortrue1Clinical ProfessorClinical Professortrue1Assistant ProfessorAssistant Professortrue1ProfessorProfessortrue1ProfessorProfessortrue1Emeritus/Emerita, ProfessorEmeritus/Emerita, Professortrue1Clinical AssociateClinical Associatetrue1ProfessorProfessortrue1Clinical Associate ProfessorClinical Associate Professortrue1Associate ProfessorAssociate Professortrue1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1Associate ProfessorAssociate ProfessorAuthorship 712266Authorship 743776Authorship 736711125314964Weiss B, Widemann BC, Wolters P, Dombi E, Vinks A, Cantor A, Perentesis J, Schorry E, Ullrich N, Gutmann DH, Tonsgard J, Viskochil D, Korf B, Packer RJ, Fisher MJNeuro-oncologySirolimus for progressive neurofibromatosis type 1-associated plexiform neurofibromas: a neurofibromatosis Clinical Trials Consortium phase II study. Neuro Oncol. 2015 Apr; 17(4):596-603.Neuro Oncol2014-10-14T00:00:002014Sirolimus for progressive neurofibromatosis type 1-associated plexiform neurofibromas: a neurofibromatosis Clinical Trials Consortium phase II study.24249806Wolters PL, Martin S, Merker VL, Gardner KL, Hingtgen CM, Tonsgard JH, Schorry EK, Baldwin A, REiNS International CollaborationNeurologyPatient-reported outcomes in neurofibromatosis and schwannomatosis clinical trials. Neurology. 2013 Nov 19; 81(21 Suppl 1):S6-14.Neurology2013-11-19T00:00:002013Patient-reported outcomes in neurofibromatosis and schwannomatosis clinical trials.Pediatrics-NeurologyAuthorship 833735826178382Rojnueangnit K, Xie J, Gomes A, Sharp A, Callens T, Chen Y, Liu Y, Cochran M, Abbott MA, Atkin J, Babovic-Vuksanovic D, Barnett CP, Crenshaw M, Bartholomew DW, Basel L, Bellus G, Ben-Shachar S, Bialer MG, Bick D, Blumberg B, Cortes F, David KL, Destree A, Duat-Rodriguez A, Earl D, Escobar L, Eswara M, Ezquieta B, Frayling IM, Frydman M, Gardner K, Gripp KW, Hernández-Chico C, Heyrman K, Ibrahim J, Janssens S, Keena BA, Llano-Rivas I, Leppig K, McDonald M, Misra VK, Mulbury J, Narayanan V, Orenstein N, Galvin-Parton P, Pedro H, Pivnick EK, Powell CM, Randolph L, Raskin S, Rosell J, Rubin K, Seashore M, Schaaf CP, Scheuerle A, Schultz M, Schorry E, Schnur R, Siqveland E, Tkachuk A, Tonsgard J, Upadhyaya M, Verma IC, Wallace S, Williams C, Zackai E, Zonana J, Lazaro C, Claes K, Korf B, Martin Y, Legius E, Messiaen LHuman mutationHigh Incidence of Noonan Syndrome Features Including Short Stature and Pulmonic Stenosis in Patients carrying NF1 Missense Mutations Affecting p.Arg1809: Genotype-Phenotype Correlation. Hum Mutat. 2015 Nov; 36(11):1052-63.Hum Mutat2015-08-21T00:00:002015High Incidence of Noonan Syndrome Features Including Short Stature and Pulmonic Stenosis in Patients carrying NF1 Missense Mutations Affecting p.Arg1809: Genotype-Phenotype Correlation.Chicago60637ILPsychologyAuthorship 93074427527648Wolters PL, Martin S, Merker VL, Tonsgard JH, Solomon SE, Baldwin A, Bergner AL, Walsh K, Thompson HL, Gardner KL, Hingtgen CM, Schorry E, Dudley WN, Franklin B, REiNS International CollaborationNeurologyPatient-reported outcomes of pain and physical functioning in neurofibromatosis clinical trials. Neurology. 2016 Aug 16; 87(7 Suppl 1):S4-S12.Neurology2016-08-16T00:00:002016Patient-reported outcomes of pain and physical functioning in neurofibromatosis clinical trials.Authorship 61392323370767Stricker TP, Henriksen KJ, Tonsgard JH, Montag AG, Krausz TN, Pytel PModern pathology : an official journal of the United States and Canadian Academy of Pathology, IncExpression profiling of 519 kinase genes in matched malignant peripheral nerve sheath tumor/plexiform neurofibroma samples is discriminatory and identifies mitotic regulators BUB1B, PBK and NEK2 as overexpressed with transformation. Mod Pathol. 2013 Jul; 26(7):930-43.Mod Pathol2013-02-01T00:00:002013Expression profiling of 519 kinase genes in matched malignant peripheral nerve sheath tumor/plexiform neurofibroma samples is discriminatory and identifies mitotic regulators BUB1B, PBK and NEK2 as overexpressed with transformation.Authorship 979491127956565Payne JM, Barton B, Ullrich NJ, Cantor A, Hearps SJ, Cutter G, Rosser T, Walsh KS, Gioia GA, Wolters PL, Tonsgard J, Schorry E, Viskochil D, Klesse L, Fisher M, Gutmann DH, Silva AJ, Hunter SJ, Rey-Casserly C, Cantor NL, Byars AW, Stavinoha PL, Ackerson JD, Armstrong CL, Isenberg J, O'Neil SH, Packer RJ, Korf B, Acosta MT, North KN, NF Clinical Trials ConsortiumNeurologyRandomized placebo-controlled study of lovastatin in children with neurofibromatosis type 1. Neurology. 2016 Dec 13; 87(24):2575-2584.Neurology2016-11-09T00:00:002016Randomized placebo-controlled study of lovastatin in children with neurofibromatosis type 1.